首页
登录
职称英语
The European Commission said on Thursday it would toughen the regulation of
The European Commission said on Thursday it would toughen the regulation of
游客
2023-11-17
71
管理
问题
The European Commission said on Thursday it would toughen the regulation of medical devices as a result of concerns raised by breast implants produced by the defunct French company PIP, even as a scientific expert review it ordered concluded there was currently "insufficient evidence" that women using its products faced greater health risks than others.
John Dalli, health and consumer policy commissioner, pledged to examine surveillance and operation of the "notified bodies" that scrutinise medical devices across the EU in a current review of legislation, stressing: "The capacity to detect and minimise the risk of fraud must be increased."
His comments followed an official report released on Wednesday in France that called for national and EU-wide co-operation including random inspections and sampling of medical devices to prevent a repeat of the fraudulent use of substandard non-medical-grade silicone by PIP in implants sold to up to 400,000 women around the world.
Xavier Bertrand, France’s minister of health, called for enhanced action in France and across Europe in the wake of the study, which highlighted that Afssaps, the French medical regulator, did not inspect PIP from 2001 until a tip-off led officials to inspect and close down the company in 2010. Jean-Claude Mas, its founder, is under police investigation for manslaughter.
Mr. Bertrand has pledged to hire more health inspectors and undertake random checks on medical device companies following growing concerns over its regulatory system highlighted by the widespread use of PIP’s substandard breast implants.
A French decision at the end of last year to offer all women free removal of PIP implants triggered similar proposals in the UK, Germany and the Czech Republic and has helped spark a fresh debate over tougher EU regulation of medical devices, which are subject to far less scrutiny than pharmaceuticals.
However, a review released on Thursday by the EU’s own Scientific Committee on Emerging and Newly Identified Health Risks concluded: "Breast implants can fail, regardless of manufacturer, and the probability of failure increases with time since implantation. In most cases, breast implant failure appears to be without identifiable health consequences for the patient with the exception of possible local complications."
It stressed that limited data meant that while there was no link between breast implants and cancer, there was a need for further work to understand the specific risks from the PIP products.
Mr. Bertrand has endorsed calls for a parliamentary inquiry in France as well as a report from the country’s social affairs inspectorate, mirroring similar moves that led to tough new requirements for the pharmaceutical industry introduced last year in the wake of concerns about Servier’s drug Mediator.
Medical device manufacturers have called for reforms to ensure that the national "notified bodies" which audit the quality of their products across Europe are of a consistently high standard, while cautioning that tough new regulatory requirements could harm the EU’s competitive advantage.
The French study showed that Afssaps had received multiple warnings over the relatively high failure rate of PIP implants compared with those made by other companies, even though the overall proportion remained modest.
From Financial Times, February 2, 2012 [br] Which of the following statements is true according to the passage?
选项
A、There is a consensus on the EU regulation of medical devices in the European Union.
B、All breast implant failure appears to be without identifiable health consequences.
C、Tough new regulatory requirements could harm the EU’s competitive advantage.
D、The overall proportion of the implant failure is relatively high compared with others.
答案
C
解析
本题为概括题。根据第六段“spark a fresh debate over tougher EU regulation of medical devices”可知A错误;根据第七段“breast implant failure appears to be without identifiable health consequences for the patient with the exception of possible local complications”可知B错误;根据倒数第二段“while cautioning that tough new regulatory requirements could harm the EU’s competitive advantage”可知C正确;根据最后一段“even though the overall proportion remained modest”可知D错误。
转载请注明原文地址:https://tihaiku.com/zcyy/3193976.html
相关试题推荐
Whatisthefocusoftheprogram?[originaltext]TheHousevotedThursdayto
1BAGHDAD,Iraq(CNNThursday,May13,2004)--DefenseSecretaryDonaldRumsfel
HowlongistheNorthernEuropeanPipeline?[br][originaltext]Beneaththe
HowlongistheNorthernEuropeanPipeline?[originaltext]BeneaththeBalti
ThedisputebetweentheEuropeanUnionandtheUnitedStatesismainlyabout[br
ThedisputebetweentheEuropeanUnionandtheUnitedStatesismainlyabout[or
AbreakthroughintheprovisionofenergyfromthesunfortheEuropeanEco
AbreakthroughintheprovisionofenergyfromthesunfortheEuropeanEco
Inthe1920sdemandforAmericanfarmproductsfell,asEuropeancountries
TheEuropeanUnionhadnotapprovedanumberofgeneticallymodifiedcropsu
随机试题
[img]2016m1x/ct_etoeiclm_etoeiclzp_0001_20161051[/img][br][originaltext](A)A
说明:请以学生会的名义于2006年5月15日拟订一个晚会通知。主题:外国语学院毕业晚会时间:2006年6月3日(星期六)晚七点地点:礼堂
Eachandeveryoneofusisresponsibleforthegreenhousegaseswesendin
Ihavebeeninstructedbymyagentthatyouowemefivedollars.A、我被我的代理告知你还欠我五美
【教学过程】 (一)创设情景,导入新课 教师播放事先做好的生日贺卡动画,让学生欣赏动画。并提出一个问题“要完成这个生日贺卡的制作,需要我们事先确定哪些内
搭便车现象是对下列()的一种形象的比喻。A.社会福利问题 B.市场失灵问题
智能制造以智能工厂为发展方向,开展智能制造试点示范,加快推动云计算、()智
按时出席宴请是礼貌的体现,一般可按规定时间提前或延后不超过( )分钟到达。A.
分离挥发油(乙醚中)的酚性成分宜选用A:碳酸钠 B:氢氧化钠 C:氢氧化钙
( )是保证培训课程的设计实现理想目标的根本保证。A.培训技术的选择 B.培
最新回复
(
0
)